Maravai LifeSciences Holdings Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everybody. We're wrapping up here. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. With me, I have Kevin Herde, CFO; and Deborah Barbara, VP, Strategy and Business Development of Maravai. So I think they're going to kick off here. Are you guys going to kick off with the presentation? Or we can dig into some questions.
Yes, we will. And thank you for having us during happy hour. Obviously, it led to a large attendance. We'll go [have drinks] afterwards, I promise. Anyway, so again, Kevin Herde, CFO. Happy to walk you all through a few slides just to kind of [tee off] Maravai and kind of refresh people on where we are, who we are, and then we'll get into your questions.
Some forward-looking statements. We do use some non-GAAP measures. So we have some caveats here with regards to that.
Overall, obviously exiting a really -- another really strong
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |